Cargando…

Why we may need to rethink future SARS-CoV-2 vaccination strategies

Detalles Bibliográficos
Autor principal:	Klimek, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433029/ https://www.ncbi.nlm.nih.gov/pubmed/34541566 http://dx.doi.org/10.1016/j.lanepe.2021.100214

Ejemplares similares

Why We Need to Rethink the Diseases of Affluence
por: Novotny, Thomas E
Publicado: (2005)

Why is the SARS-CoV-2 Omicron variant milder?
por: Xia, Bingqing, et al.
Publicado: (2022)

Which trial do we need? Management of elderly, fragile, fully vaccinated patients hospitalized for SARS-CoV-2 infection
por: Trøseid, Marius, et al.
Publicado: (2023)

Why we still need drugs for COVID‐19 and can't just rely on vaccines
por: Robinson, Bruce W. S., et al.
Publicado: (2021)

Why do we need improved mobility technology?
por: Boninger, Michael L, et al.
Publicado: (2012)

Why Do We Need To Diversify the Microbial Sciences?
por: Torres, Alfredo G.
Publicado: (2021)

Letter: A Note on Neurosurgical Resection and Why We Need to Rethink Cutting
por: Picht, Thomas, et al.
Publicado: (2021)

Plasmodium vivax malaria vaccines: Why are we where we are?
por: Reyes-Sandoval, Arturo, et al.
Publicado: (2013)

Equity-Oriented Healthcare: What It Is and Why We Need It in Oncology
por: Horrill, Tara C., et al.
Publicado: (2022)

Vaccine as a Platform (VaaP): Why the future of disease eradication needs to be data driven
por: Justhy, Deva Prasad
Publicado: (2020)

How do we best relax control measures as vaccine coverage for SARS-CoV-2 rises?
por: Foy, Brody H, et al.
Publicado: (2021)

Why do we need better omics in the breast cancer care?
por: Gertych, Arkadiusz, et al.
Publicado: (2021)

Monkey pox: Rethinking COVID‐19 to project future strategies against emerging and evolving pathogens
por: Lamptey, Emmanuel, et al.
Publicado: (2022)

SARS-CoV-2 transmission: time to rethink public health strategy
por: Parker, Arifa, et al.
Publicado: (2022)

SARS‐CoV‐2 Omicron variant: Why global communities should take it seriously?
por: Rahmani, Shayan, et al.
Publicado: (2022)

Low genetic diversity may be an Achilles heel of SARS-CoV-2
por: Rausch, Jason W., et al.
Publicado: (2020)

We need people’s WHO to solve vaccine inequity, and we need it now
por: Kim, Hani
Publicado: (2021)

Developing Vaccines for SARS-CoV-2 and Future Epidemics and Pandemics: Applying Lessons from Past Outbreaks
por: Billington, John, et al.
Publicado: (2020)

Why do we need male contraceptives?
por: Cheng, C Yan, et al.
Publicado: (2013)

Zoonotic origins of human coronavirus 2019 (HCoV-19 / SARS-CoV-2): why is this work important?
por: Wong, Gary, et al.
Publicado: (2020)

Vaccine breakthrough infections with SARS-CoV-2: Why older adults need booster vaccinations
por: Ventura, Maria I., et al.
Publicado: (2022)

Timely development of vaccines against SARS-CoV-2
por: Lu, Shan
Publicado: (2020)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

Is there a post-SARS-CoV-2 vaccination dementia?
por: Fiorini, Ana C., et al.
Publicado: (2022)

Why you may need a neurologist to see a comatose patient in the ICU
por: Wijdicks, Eelco F. M.
Publicado: (2016)

If the treatment works, do we need to know why?: the promise of immunotherapy for experimental medicine
por: Ehrenstein, Michael R., et al.
Publicado: (2007)

Public health physicians: who are they and why we need more of them – especially in Victoria
por: Wilson, Alyce N., et al.
Publicado: (2021)

Why Design Thinking in Business Needs a Rethink
por: Kupp, Martin
Publicado: (2017)

Changing the Conversation, Why We Need to Reframe Corruption as a Public Health Issue: Comment on "We Need to Talk About Corruption in Health Systems"
por: Clarke, David
Publicado: (2019)

A role for prophylactic antibiotics in necrotizing pancreatitis? Why we may never know the answer ...
por: De Waele, Jan J
Publicado: (2008)

SARS-CoV-2-mediated inflammatory response in lungs: should we look at RAGE?
por: Rojas, Armando, et al.
Publicado: (2020)

SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Unanticipated efficacy of SARS-CoV-2 vaccination in older adults
por: Pawelec, Graham, et al.
Publicado: (2021)

Multicomponent vaccines to fight SARS-CoV-2 variants of concern
por: Cassone, Antonio, et al.
Publicado: (2021)

The challenge of emerging SARS-CoV-2 mutants to vaccine development
por: Li, Rong, et al.
Publicado: (2021)

SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?
por: Antonopoulou, Tania, et al.
Publicado: (2022)

Questioning the justification for a fourth SARS-CoV-2 vaccine
por: Calderon-Margalit, Ronit, et al.
Publicado: (2022)

Listening in the dark: why we need stories of people living with severe and enduring anorexia nervosa
por: Conti, Janet, et al.
Publicado: (2016)

The “case” for case studies: why we need high-quality examples of global implementation research
por: Beecroft, Blythe, et al.
Publicado: (2022)

SARS-CoV-2 epitopes inform future vaccination strategies
por: Shafqat, Areez, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jct27tnmej1m01k9sa0j4qckb1